Summary
Определение
History and exam
Key diagnostic factors
- persistent or repetitive tonic-clonic seizures with altered level of consciousness (generalized convulsive status epilepticus)
- altered awareness/confusion (nonconvulsive status epilepticus)
Other diagnostic factors
- focal status epilepticus without impaired consciousness
- low oxygen saturation
Risk factors
- nonadherence to anticonvulsants
- alcohol use disorder
- stroke
- refractory epilepsy
- toxic or metabolic causes
- processes leading to direct cortical structural damage
- use of certain drugs
Diagnostic tests
1st tests to order
- anticonvulsant blood level
- toxicology screen
- comprehensive metabolic panel
- CBC
- ECG
- electroencephalography (EEG)
Tests to consider
- ABG
- CT head
- lumbar puncture
- MRI head
- continuous electroencephalography (cEEG)
Treatment algorithm
generalized convulsive status epilepticus
nonconvulsive status epilepticus
Contributors
Expert advisers
Emily L. Johnson, MD
Associate Professor of Neurology
Johns Hopkins Medical Institutions
Baltimore
MD
Divulgaciones
ELJ declares that she has no competing interests.
Agradecimientos
Dr Emily L. Johnson would like to gratefully acknowledge Dr Ronald P. Lesser, Dr Mohammad Koubeissi, and Dr Nabil Azar, previous contributors to this topic.
Divulgaciones
RPL or his wife have stock in the following companies, which sell healthcare products: Abbott Labs, Apple, Avanos, Celgene, Express Scripts, Johnson and Johnson, and Pfizer. MK declares that he has no competing interests. NA declares that he has no competing interests.
Revisores por pares
Maria Jose Bruzzone Giraldez, MD
Assistant Professor Epilepsy Division
University of Florida
Gainesville
FL
Divulgaciones
None
Yvonne Hart, MBBS
Consultant Neurologist
John Radcliffe Hospital
Oxford
UK
Divulgaciones
YH has been reimbursed by UCB Pharma Ltd, Janssen-Cilag Ltd, Pfizer Ltd, and Eisai Ltd for attending conferences; has taught at meetings sponsored by the above companies and by GlaxoSmithKline Services Unlimited; and has received payment for advisory board work from UCB Pharma Ltd, Janssen-Cilag Ltd, Eisai Ltd, and GlaxoSmithKline Services Unlimited.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
Brophy GM, Bell R, Claassen J, et al; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012 Aug;17(1):3-23. Resumen
Glauser T, Shinnar S, Gloss D. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016 Jan-Feb;16(1):48-61.Texto completo Resumen
National Institute for Health and Care Excellence. Epilepsies in children, young people and adults. Jan 2025 [internet publication].Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Nonepileptic status epilepticus (SE)
- Delirium
- Coma
Más DiferencialesGuías de práctica clínica
- Emergency management of the paediatric patient with convulsive status epilepticus
- Evidence-based guideline: treatment of convulsive status epilepticus in children and adults
Más Guías de práctica clínicaFolletos para el paciente
Epilepsy: what is it?
Epilepsy: what treatments work?
Más Folletos para el pacienteInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad